Theranos Issues Tens Of Thousands Of Corrected Blood-Test Reports
The startup voided two years of results and revised other reports in an effort to stave off harsh sanctions from the Centers for Medicare & Medicaid Services.
The Wall Street Journal:
Theranos Voids Two Years Of Edison Blood-Test Results
Theranos Inc. has told federal health regulators that the company voided two years of results from its Edison blood-testing devices, according to a person familiar with the matter. The Edison machines were touted as revolutionary and were the main basis for the $9 billion valuation attained by the Palo Alto, Calif., company in a funding round in 2014. But Theranos has now told regulators that it threw out all Edison test results from 2014 and 2015. The company has told the Centers for Medicare and Medicaid Services that it has issued tens of thousands of corrected blood-test reports to doctors and patients, voiding some results and revising others, according to the person familiar with the matter. (Carreyrou, 5/18)
Theranos Issues Thousands Of Blood-Test Corrections
Theranos spokeswoman Brooke Buchanan said Wednesday that no patients suffered harm due to the inaccurate tests, citing an analysis conducted by the company. She declined to provide details of the analysis. (McLean, 5/19)